We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $69.5B Turnover 9.58%
1-Year Est. Return 31.38%
This Fund
S&P 500
This Quarter Est. Return
+0.97%
1 Year Est. Return
+31.38%
3 Year Est. Return
+126.98%
5 Year Est. Return
+155.3%
10 Year Est. Return
+569.87%
AUM
$7.23B
AUM Growth
-$1.26B
Cap. Flow
-$1.29B
Cap. Flow %
-17.85%
Top 10 Hldgs %
17.57%
Holding
1,950
New
32
Increased
184
Reduced
1,428
Closed
301
Avg Time Held
1.7 years
Top 10 Avg Time Held
1 year
Top 20 Avg Time Held
1.5 years

Sector Composition

Rank Sector Weight
1 Healthcare 20.89%
2 Technology 15.67%
3 Financials 15.46%
4 Consumer Discretionary 7.66%
5 Communication Services 7.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
AAPL icon
1
Apple
AAPL
$4.98T
$322M 4.45%
10,258,872
-2,960,768
-22% -$94.7M
2013 Q2
8 quarters
MSFT icon
2
Microsoft
MSFT
$3.6T
$156M 2.17%
3,544,334
-1,042,451
-23% -$47.6M
2013 Q2
8 quarters
GOOG icon
3
Alphabet (Google) Class C
GOOG
$3.25T
$136M 1.88%
5,135,180
-1,426,867
-22% -$38.2M
2013 Q2
8 quarters
GILD icon
4
Gilead Sciences
GILD
$206B
$125M 1.73%
1,067,344
-198,987
-16% -$21.7M
2013 Q2
8 quarters
XOM icon
5
ExxonMobil
XOM
$653B
$98.5M 1.36%
1,184,436
-166,502
-12% -$14.3M
2013 Q2
8 quarters
AMGN icon
6
Amgen
AMGN
$236B
$97.4M 1.35%
634,264
-68,576
-10% -$11M
2013 Q2
8 quarters
BIIB icon
7
Biogen
BIIB
$36.9B
$88.1M 1.22%
218,087
-18,958
-8% -$7.61M
2013 Q2
8 quarters
CELG
8
DELISTED
Celgene
CELG
$85.8M 1.19%
741,524
-53,358
-7% -$6.1M
2013 Q2
8 quarters
META icon
9
Meta Platforms (Facebook)
META
$1.43T
$80.9M 1.12%
943,646
-256,276
-21% -$20.9M
2013 Q2
8 quarters
JPM icon
10
JPMorgan Chase
JPM
$825B
$79.5M 1.1%
1,173,792
-182,212
-13% -$11.9M
2013 Q2
8 quarters
AMZN icon
11
Amazon
AMZN
$2.67T
$75.5M 1.05%
3,480,520
-980,820
-22% -$20.5M
2013 Q2
8 quarters
JNJ icon
12
Johnson & Johnson
JNJ
$651B
$74.7M 1.03%
766,502
-93,339
-11% -$9.35M
2013 Q2
8 quarters
WFC icon
13
Wells Fargo
WFC
$236B
$74M 1.02%
1,315,435
-191,491
-13% -$10.7M
2013 Q2
8 quarters
INTC icon
14
Intel
INTC
$273B
$70.7M 0.98%
2,324,726
-642,327
-22% -$20.8M
2013 Q2
8 quarters
BRK.B icon
15
Berkshire Hathaway Class B
BRK.B
$1.21T
$69.7M 0.97%
512,354
-73,559
-13% -$10.5M
2013 Q2
8 quarters
CVX icon
16
Chevron
CVX
$407B
$63.6M 0.88%
659,487
-89,352
-12% -$9.38M
2013 Q2
8 quarters
CSCO icon
17
Cisco
CSCO
$357B
$62.4M 0.86%
2,271,999
-637,537
-22% -$18.3M
2013 Q2
8 quarters
REGN icon
18
Regeneron Pharmaceuticals
REGN
$95.2B
$59.8M 0.83%
117,160
-11,278
-9% -$5.5M
2013 Q2
8 quarters
CMCSA icon
19
Comcast
CMCSA
$88.4B
$53.4M 0.74%
1,776,070
-519,540
-23% -$15.3M
2013 Q2
8 quarters
PG icon
20
Procter & Gamble
PG
$393B
$51M 0.71%
652,086
-75,903
-10% -$6.11M
2013 Q2
8 quarters
BAC icon
21
Bank of America
BAC
$325B
$50.2M 0.7%
2,951,500
-418,685
-12% -$6.9M
2013 Q2
8 quarters
C icon
22
Citigroup
C
$183B
$49.5M 0.68%
895,979
-76,363
-8% -$4.15M
2013 Q2
8 quarters
GS icon
23
Goldman Sachs
GS
$228B
$48.9M 0.68%
234,147
-45,563
-16% -$9.28M
2013 Q2
8 quarters
WBA icon
24
DELISTED
Walgreens Boots Alliance
WBA
$48.2M 0.67%
571,132
-114,390
-17% -$9.9M
2013 Q2
8 quarters
MMM icon
25
3M
MMM
$91.8B
$45.4M 0.63%
351,679
-43,820
-11% -$5.88M
2013 Q2
8 quarters

Similar funds

ProShare Advisors's Q2 2015 Portfolio in Review

As of Q2 2015, ProShare Advisors held 1,950 positions worth $7.23B, down 15% from $8.49B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

ProShare Advisors withdrew a net $1.29B in Q2 2015, closing 301 positions and reducing 1,428 holdings. Its most notable exit was Pharmacyclics, an estimated $16.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Financials.

Against the trend, ProShare Advisors opened a new position in Uniti Group worth $1.66M.

  • ProShare Advisors's largest Q2 2015 buy was Uniti Group: 67,007 shares worth $1.66M.
  • ProShare Advisors added most to Equinix in Q2 2015, an estimated $4.63M increase.
  • ProShare Advisors's biggest Q2 2015 reduction was Apple, cutting an estimated $94.7M.
  • ProShare Advisors fully exited Pharmacyclics in Q2 2015, selling an estimated $16.5M.
  • ProShare Advisors's ten largest holdings make up 18% of its $7.23B portfolio in Q2 2015.
  • ProShare Advisors opened 32 new positions and closed 301 in Q2 2015.
  • ProShare Advisors's portfolio value fell 15% quarter-over-quarter to $7.23B.

Based on ProShare Advisors's 13F filing for Q2 2015, filed 11 Aug 2015.